Vorabbekanntmachung | 12 April 2023 16:25 Epigenomics AG / Preliminary announcement on the disclosure of financial statements Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] 12.04.2023 / 16:25 CET/CEST Preliminary announcement of the publication of financial reports according to Articles […]
Year: 2023
12. April 2023
Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
Read more
12. April 2023
Epigenomics AG: Changes in the Management
Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Changes in the Management 12-Apr-2023 / 19:56 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Epigenomics AG: Changes in […]
12. April 2023
Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Chief Executive Officer Greg Hamilton Resigns 12.04.2023 / 20:05 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns Berlin (Germany), April 12, 2023 – The Chief Executive Officer of Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; […]
20. March 2023
Epigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act
Ad-hoc | 20 März 2023 20:19 Epigenomics AG / Key word(s): Change in Forecast/Miscellaneous Epigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act 20-March-2023 / 20:19 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by […]
20. March 2023
Epigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act
Epigenomics AG / Key word(s): Change in Forecast/MiscellaneousEpigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act 20-March-2023 / 20:19 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group […]
10. March 2023
Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations)
EQS-News: Epigenomics AG / Key word(s): Miscellaneous/Restructure of CompanyEpigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations) 10.03.2023 / 09:37 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with […]